St. Louis Park-based Achieving Cures Together will host a virtual event, Spread Hope, to hear from experts around the nation sharing highlights of their research and clinical trials that they say connects microbial health to autism, cancer recovery and gastrointestinal health. Guest speakers include Dr. Alexander Khoruts, Dr. James Adams, Dr. Rosa Krajmalnik-Brown, Dr. Byron Vaughn and Dr. Shernan Holtan.
read morePreliminary research suggests microbiota screening could serve as an accurate diagnostic screening tool for cardiovascular disease.
read moreNew research demonstrated significant direct communications between the central nervous system and the gut, finding that microbiota modulate sympathetic neurons through the gut-brain circuit.
read moreResearchers in California have discovered specific gut bacteria strains useful in detecting liver fibrosis and cirrhosis with an accuracy of greater than 90 percent.
read moreIn new study completed in Switzerland and the UK, researchers identified a specific strain of bacteria as a potential trigger for the early stages of Rheumatoid Arthritis.
read moreAlthough the concept of beneficial bacteria is no longer novel, in recent decades there has been increasing attention paid to the potential effects of probiotics. Generally, existing research supports that probiotics have rather limited benefits that extend only to specific conditions. While probiotics may be limited, microbial therapeutics including Intestinal Microbiota Transplants (IMT) are increasingly being used to treat specific diseases and conditions.
read moreFor the U of M's Microbiota Therapeutics Program team, this work is personal. Amanda Kabage's life saving Intestinal Microbiota Transplant not only gave her health back, but a new career focus.
read moreExposure to air pollution alters gut microbiome composition, subsequently increases the risk of obesity, diabetes, and other chronic illnesses.
read moreA study in mice suggests that by infiltrating tumors and ramping up the body’s immune response, a type of gut bacteria could be a valuable ally in cancer treatment.
read moreThe study, a collaborative work conducted by researchers from Deakin University, Barwon Health and the Murdoch Children’s Research Institute (MCRI) – is the first to show that children with a lower amount of Prevotella at age one are more likely to have anxiety-like behaviours at two, supporting what Harvard researchers have termed “the gut-brain connection”.
read more
